Video

Reaching Black Cardiovascular Patients by Text Message

Author(s):

A pilot trial from Perelman showed patients were far more likely to provide blood pressure levels via text than a standard online patient portal.

A pilot trial from cardiologists at the Perelman School of Medicine at the University of Pennsylvania showed a selected group of their black patients with uncontrolled hypertension or cardiovascular risks were more likely to submit at-home blood pressure monitoring levels to their clinicians via text versus a provided online patient portal.

The study, led by Jennifer Lewey, MD, MPH, Director of the Penn Women’s Cardiovascular Center and colleagues, warranted follow-up with a greater pool of patients while also showing the unique patient-by-patient preferences for telehealth.

In an interview with HCPLive, Lewey discussed the significance of first assessing text-versus-portal blood pressure monitoring engagement in a population of Black patients with uncontrolled disease and Medicare or Medicaid.

“The motivation behind doing this was to really understand the best ways to improve blood pressure monitoring at home, especially knowing the higher rates of hypertension, uncontrolled hypertension, and cardiovascular morbidity and mortality experienced by Black individuals,” Lewey explained. “We put the burden on the patient—we try to empower them with self-monitoring, but then the ball is dropped. So we never get those numbers until 6 months, 12 months later when someone comes in, and it’s a missed opportunity.”

Lewey also shared the benefit of the small trial’s setup, which allowed for direct patient feedback on the 2 different methods provided for follow-up telehealth.

“For those who were using the online patient portal, I was really surprised by the number of individuals who mentioned they had to have their child or someone else in the household submit their blood pressures because even though we gave people instructions and most of them were already signed up for the portal, it just wasn’t intuitive or easy to use,” Lewey said.

Lastly, Lewey discussed the surprisingly effective value of simplified text message telehealth to improve patient buy-in.

“I think getting that immediate feedback…it was really motivating for people,” she said. “I think that really brings up the question of how can we make that process feel more personalized, and how can you have some of those behavioral nudges to engage in their care.”

Related Videos
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
What to Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
© 2024 MJH Life Sciences

All rights reserved.